Case Studies, Pharmaceutical

Case Study – Unidose Nasal Spray Pump for Opioid Overdose

Although naloxone has long been available in injection format as a treatment for opioid overdose, administration relies on the presence of a suitably trained responder. This case study describes a collaborative drug repurposing project with Aptar Pharma to develop an easy-to-administer naloxone nasal spray. The resulting product has been successfully commercialized to broaden access to a life-saving therapeutic. Utilizing Aptar Pharma’s Unidose Liquid (UDS) system, it is primeless, reliable, and intuitive. Collaboration accelerated time to market for the nasal spray via the FDA’s 505(b)(2) Abbreviated Approval Pathway (U.S.) creating valuable intellectual property. The global market for the product is in excess of $350 million (2021).

Download Case Study - Unidose Nasal Spray pump for opioid overdose
8 Sep 2022

Learn more about Aptar Pharma Expertise
in Nasal Drug Delivery

Find Out More About nasal drug delivery expertise

This Might Also Be of Interest

8 Oct 2024

Understanding PBPK Modeling in OINDPs: Insights from Will Ganley

Publications, Pharmaceutical, Market Insights, Product Solutions

Read More
2 Oct 2024

Advancing Nose to Brain Drug Delivery: Intranasal Administration of Insulin

Publications, Pharmaceutical, Product Solutions, Innovation & Insights, Device Innovations, Market Insights

Read More
30 Sep 2024

Cyclosporine – A Micellar Nasal Spray: A Promising Antiviral Solution Against S...

Publications, Pharmaceutical, Device Innovations, Market Insights, Product Solutions

Read More
24 Apr 2024

Advancing OINDP Clinical Trials with Speed and Efficiency: Strategies for Success

Publications, Pharmaceutical, Market Insights, Product Solutions, Innovation & Insights

Read More
1 2 3 26

Request Access

Close

Requesting access to Case Study – Unidose Nasal Spray Pump for Opioid Overdose.

  • This field is for validation purposes and should be left unchanged.
Back To Top